Author:
Shah Shamsul Azhar,Anuar Haryati,Abdul Gafor Abdul Halim,Abdullah Nik Nairan
Abstract
AbstractPurpose We aimed to determine predictors of chronic kidney disease (CKD) prevention among patients with diabetes. Method A cross-sectional study was conducted on 1000 selected respondents based on socio-demographic, socio-economic, general CKD perception knowledge, self-monitoring advocacy, preventive behavior, treatment compliance, and psychosocial factors. Using multiple logistic regression, variables and their association with impaired perception of CKD prevention were analyzed. Results Overall, 74% had poor perception regarding CKD prevention (68.7% of men and 31.3% of women). In multivariable analysis, those with weak illness identity fear were two times more likely to have poor perceptions (95% CI 1.563–3.196, p < 0.001). Respondents with weak medical practice (AOR = 2.33, 95% CI 1.609–2.381, p < 0.001) and weak cooperation (AOR = 1.563; 95% CI 1.099–2.224, p < 0.001) were more likely to have poor perceptions on CKD prevention. Concerning poor perception, significant predictors were self-employment, housewives, working in private jobs, weak knowledge on clear glycosuria, sleep problems, print media, digital media, illness identity fear, weak medical practice, and weak co-operation factors. Conclusion Media support is crucial for supporting and improving positive views regarding CKD knowledge. Interventions to reach people with limited awareness on CKD prevention, lower socioeconomic status, and poor social support may improve identification of patients with early-stage CKD. Particular care should be taken to recognize and provide necessary services regarding the early detection of CKD.
Publisher
Springer Science and Business Media LLC
Reference21 articles.
1. Weisbord, S. D., McGill, J. B. & Kimmel, P. L. Psychosocial factors in patients with chronic kidney disease. Natl. Kidney Found. (NKF) https://doi.org/10.1053/j.ackd.2007.07.012 (2007).
2. Kidney International Supplements. The 2011 kidney disease: improving global outcomes (KDIGO). (2012), https://doi.org/10.1038/kisup.2012.6.
3. Frishman, W. H. Importance of medication adherence in cardiovascular disease and the value of once-daily treatment regimens. Cardiol. Rev. 15(5), 257–263 (2007).
4. Burnier, M., Pruijm, M., Wuerzner, G. & Santschi, V. Drug adherence in chronic kidney diseases and dialysis. Nephrol. Dial. Transpl. 30(1), 39–44. https://doi.org/10.1093/ndt/gfu015 (2015).
5. Ricardo et al. Validation of the kidney disease quality of life short form 36 (KDQOL-36™) US Spanish and English versions in a cohort of hispanics with chronic kidney disease. PMC Spring; 23, 202–209 (2013).
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献